Pacer Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,509,609 shares of HRMY stock, worth $104 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,509,609
Previous 2,494,914
0.59%
Holding current value
$104 Million
Previous $83.8 Million
9.63%
% of portfolio
0.19%
Previous 0.22%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
226Shares Held
45.1MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$465 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$242 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$146 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$108 Million11.62% of portfolio
-
State Street Corp Boston, MA1.27MShares$52.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.45B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...